Breaks Categories: News

ThursdayJan 27, 2022 12:33 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is…

Continue Reading

ThursdayJan 27, 2022 11:09 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp.…

Continue Reading

ThursdayJan 27, 2022 10:31 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet's patients using RYAH Smart Inhalers and data analytics, once certified as a medical device in Israel, with the goal of providing safe and accurate patient inhalation therapies in plant medicine. “Bazelet brings extraordinary depth and expertise within a well-established and fast-growing medical cannabis market. We're excited to be collaborating with Bazelet in bringing our smart…

Continue Reading

TuesdayJan 25, 2022 1:22 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Submits NNCP Filing with Health Canada

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, announced that it has filed Form 8-K with Health Canada; the filing is GPFT’s Notice of New Cannabis Product (“NNCP”) with Health Canada. Once GPFT receives approval of the NNCP from Health Canada, the company will be able to offer its patented Hourglass(TM) Time Release THC+CBD-Infused Topical Delivery Cream under the Canadian Federal Cannabis Act throughout Canada. The act, which became effective in 2018, provides national guidelines for legal access to cannabis as well as the product, distribution and sale of the substance. Canada became the second country in the world…

Continue Reading

TuesdayJan 25, 2022 1:11 pm

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Strategic Distribution Agreement Between Wholly Owned cDistro and dosist health

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced that its wholly owned subsidiary cDistro has reached an agreement with dosist health to distribute its award-winning line of high concentration CBD+ formulas and products. According to the update, cDistro will expand the rapidly growing distribution locations for dosist health CBD products to drive sales and further establish cDistro in the distribution marketplace. “This agreement represents a tremendous opportunity for cDistro,” said cDistro's President Ron Russo. “I look forward to working with dosist health and their award-winning product portfolio to…

Continue Reading

MondayJan 24, 2022 1:57 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Renowned Genetics, Cultivation Expert as Advisor

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Derek Pedro, an industry-leading cannabis genetics and cultivation expert, as an advisor. Pedro is recognized as a pioneer in the cannabis industry and has consulted on cannabis genetic and cultivation projects around the world, including Canada, the United States, Latin America, Europe and China. In his role at FLGC, he will focus on developing the company’s current register of high-THC and high-CBD strains. The company hopes to offer cannabis flower offerings that are uniquely Colombian to both domestic and international markets. Flora…

Continue Reading

MondayJan 24, 2022 10:21 am

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Moves to Enter Rare Cannabinoid Market Through License Agreement for Patented THC-V-Rich Chemovars

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, today announced its entry into a binding letter of intent (“LOI”) with GenCann Inc., the exclusive licensor for a set of cannabis chemovars particularly rich in the cannabinoid tetrahydrocannabivarin (“THC-V”) (the “GenCann Chemovars”). Under the terms of the LOI, Sugarmade and its licensed cannabis cultivator partners will be granted a five-year license to cultivate what the company believes to be some of the highest THC-V-containing strains in existence. Sugarmade and GenCann plan to begin immediate clone production, upon the signing of the final agreement, with a cultivation program beginning…

Continue Reading

ThursdayJan 20, 2022 1:06 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Featured in EDGE Podcast Interview

Lexaria Bioscience (NASDAQ: LEXX) CEO and chair Chris Bunka is the guest on a recent episode of the EDGE podcast. Hosted by entrepreneur and angel investor Brandon C. White, the EDGE is a podcast series focused on providing a playbook for business owners that takes a look at the inner game of building a successful business and giving listeners the edge to become smarter, healthier and richer. Lexaria Bioscience is a global innovator in drug-delivery platforms. During the interview, Bunka shared his background and the journey that led him to Lexaria. He also talked about Lexaria’s business model and the…

Continue Reading

WednesdayJan 19, 2022 12:12 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that it has launched B2B sales of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector. According to the update, CBT is the first of several new product launches the company has planned for the first half of 2022. “We are delivering on our objective to launch additional rare cannabinoids in early 2022 in response to inbound demand. By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a…

Continue Reading

TuesdayJan 18, 2022 4:11 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2. The comments came from lead research scientist Dr. Richard van Breeman, who granted an interview with vice.com discussing the independent study. In his comments, Breemen observed that smoking or vaping of cannabis was likely not effective, but oral delivery was, causing Breeman to recommend oral administration of cannabis compounds. Lexaria is keenly interested in the study because the company is actively engaged in research with its exclusive DehydraTECH(TM)-powered cannabinoid formulations,…

Continue Reading